Approval · Notice of Compliance 5744 · 1994
LENTARON: Notice of Compliance 5744
Issued August 25, 1994
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5744
- Date
- August 25, 1994
- Company
- Geigy Pharmaceuticals, Ciba-Geigy Canada Ltd.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Steroidal aromatase inhibitor, inhibitor of estrogen biosynthesis, antitumour agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| LENTARON | 02128209 | Cancelled Post Market |
Medicinal ingredients
- FORMESTANE 250 MG per KIT
- SODIUM CHLORIDE 0.9 PER per KIT